Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate
- 1 October 2001
- journal article
- review article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 51 (2) , 419-425
- https://doi.org/10.1016/s0360-3016(01)01639-x
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Therapeutic management of primary central nervous system lymphoma: Lessons from prospective trialsAnnals of Oncology, 2000
- Long-term survival in primary CNS lymphoma.Journal of Clinical Oncology, 1998
- High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.Journal of Clinical Oncology, 1998
- Primary lymphoma of brain: results of management of a modern cohort with radiation therapyRadiotherapy and Oncology, 1997
- Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: Results of a critical review of the literatureAnnals of Oncology, 1997
- Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy.Journal of Clinical Oncology, 1996
- Primary Central Nervous System LymphomaAnnals of Internal Medicine, 1993
- Combined modality therapy for primary CNS lymphoma.Journal of Clinical Oncology, 1992
- Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation therapy Oncology Group (RTOG): RTOG 8315International Journal of Radiation Oncology*Biology*Physics, 1992
- High-dose methotrexate for non-AIDS primary central nervous system lymphomaJournal of Neurosurgery, 1989